Jacob Eikelenboom

Title: Jacob Eikelenboom: Innovator in Pharmaceutical Compositions

Introduction

Jacob Eikelenboom is a notable inventor based in MZ Haarlem, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating central nervous system disorders. With a total of 2 patents to his name, Eikelenboom's work is recognized for its innovative approach to medication delivery.

Latest Patents

Eikelenboom's latest patents focus on pharmaceutical compositions comprising rotigotine salts, specifically designed for iontophoresis. These inventions relate to new salts of 6-(propyl-(2-thiophen-2-ylethyl)amino)tetralin-1-ol (rotigotine) and their application as a medicament for treating conditions such as Parkinson's Disease, Restless Legs Syndrome (RLS), fibromyalgia, and depression. The formulations are characterized by their enhanced iontophoretic delivery capabilities and excellent solubility in aqueous solutions, making them suitable for electromotive administration.

Career Highlights

Eikelenboom is currently associated with UCB Pharma GmbH, where he continues to advance his research and development efforts in the pharmaceutical sector. His work has contributed to the understanding and treatment of various CNS disorders, showcasing his commitment to improving patient outcomes through innovative solutions.

Collaborations

Some of Eikelenboom's notable coworkers include Johanna Aaltje Bouwstra and Oliver Ackaert. Their collaborative efforts have further enriched the research environment at UCB Pharma GmbH, fostering innovation and development in pharmaceutical sciences.

Conclusion

Jacob Eikelenboom stands out as a significant figure in the field of pharmaceuticals, with his innovative patents paving the way for advancements in the treatment of CNS disorders. His contributions reflect a dedication to enhancing medication delivery and improving patient care.